Search results with tag "Sofosbuvir"

AMIODARONE DRUG MONITORING GUIDELINE

www.rotherhamccg.nhs.uk

(Harvoni ® [sofosbuvir with ledipasvir] or a combination of Sovaldi [sofosbuvir] and Daklinza® [daclatasvir]) may increase the risk of severe bradycardia or heart block . Simvastatin: Rarely, myopathy and rhabdomyolysis have been reported in people taking amiodarone with high doses of simvastatin. The dose of simvastatin should not exceed 20 mg a

Sofosbuvir

(sofosbuvir/velpatasvir)tablets 400mg/100mg …

www.gilead.ca

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrEPCLUSA™ (sofosbuvir/velpatasvir)tablets 400mg/100mg Antiviral Agent Gilead Sciences Inc. Foster City, CA 94404

Tablets, Sofosbuvir, 100mg, Antiviral, 400mg, Sofosbuvir velpatasvir, Velpatasvir, Tablets 400mg 100mg, Tablets 400mg 100mg antiviral

C型肝炎治療的新選擇―― Sovaldi® …

www.aids-care.org.tw

13 C型肝炎治療的新選擇―― Sovaldi® ®Tablets（Sofosbuvir）及 Harvoni®® Tablets（Ledipasvir plus Sofosbuvir）之介紹謝思民

Sofosbuvir

EASL Recommendations on Treatment of Hepatitis C 2016 …

www.easl.eu

3 11. Treatment monitoring 11.1.Monitoring of treatment efficacy 11.2.Monitoring of treatment safety 11.2.1. Sofosbuvir and ledipasvir 11.2.2. Sofosbuvir and velpatasvir

Treatment, Recommendations, Hepatitis, Sofosbuvir, Recommendations on treatment of hepatitis, Velpatasvir

Pharmacy Medical Policy Hepatitis C Medication …

www.bluecrossma.com

5 OR genotype 1a or 3 infection AND have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor.

Policy, Medical, Medication, Hepatitis, Sofosbuvir, Medical policy hepatitis c medication

Sofosbuvir Report updated final 2015-03-17 - WHO

www.who.int

4 INTRODUCTION The World Health Organization’s (WHO) 2014 Guidelines for the screening, care and treatment of persons with hepatitis C infection state that worldwide more than 185 million

Health, Report, Updated, World health organization, World, Organization, 2015, Final, Sofosbuvir report updated final 2015, Sofosbuvir